CHEMICAL COMPATIBILITY

| July 18, 2017

article image
The following information is intended to be used as a general guideline for pump material selection. The information accuracy of these ratings cannot be guaranteed, nor is it a complete list due to the extensive area of this field. Materials used in the pump and pumping systems must be chemically compatible.The data provided for the chemicals is at 70ºF (21ºC), unless otherwise noted. If your temperature differs from this, it may affect the compatibility of the fluid with the given pump materials by accelerating the reaction.

Spotlight

Trevena, Inc.

Trevena, Inc. is a clinical stage biopharmaceutical company that discovers, develops, and intends to commercialize innovative therapies that use a novel approach to target G protein coupled receptors, or GPCRs. We are dedicated to providing value to patients and healthcare providers by improving patient outcomes and reducing healthcare costs. We have identified four biased ligand drug candidates: TRV130, an FDA-designated Breakthrough Therapy, is currently in phase 3 testing for the intravenous treatment of acute moderate to severe pain; TRV027 was evaluated in a Phase 2b study for the treatment.

OTHER ARTICLES

Improving Pump Seal Reliability for Bay Area Petrochem Plants

Article | March 10, 2020

Keeping thousands of pumps in San Francisco Bay Area refineries running 24/7/365 requires a well-planned and well-executed maintenance strategy. Unplanned failures may have ramifications for safety, budget, and compliance—especially with regard to Bay Area Air Quality Management District (BAAQMD) regulations. One of the most mission-critical elements for smooth operations is pump seal reliability. Many plants run pumps outside the safe operating envelope and replace them only when economically feasible. Over time, however, you increasingly risk catastrophic downtime. Fortunately, you have the means to largely mitigate pump seal reliability problems with awareness and proactive management of conditions to improve safety and compliance.

Read More

Euric unveils Waste & chemicals brochure

Article | February 11, 2020

Recyclers have developed state-of-art separation techniques to safely treat a wide diversity of waste streams and recover valuable materials, hence directly contributing to the circular economy. The Brochure published by Euric on ‘Sound Management of Waste & Chemicals Requirements’ highlights the main issues derived from the lack of interface between chemicals, product and waste legislation, and identifies simple solutions to boost the transition towards a more circular economy. Christer Forsgren, Chair of the Euric’s Waste & Chemicals Task Force, Environmental & Technical Director at Stena Metall AB (Sweden), and Adjunct Professor in Industrial Material Recycling at Chalmers Technical University in Gothenburg, emphasized the key role that Europe’s recycling industry plays by reducing Europe’s dependency on primary materials and by saving massive amounts of CO2 and energy.

Read More

ACC's Jahn discusses how the chemical industry is combating COVID-19

Article | April 6, 2020

The U.S. chemical industry has a vital role to play in response to COVID-19. Following President Trump’s declaration of a national emergency, one of the first steps the American Chemistry Council took on behalf of its members was to secure federal designation of the U.S. chemical industry and its workers as “essential critical infrastructure.” This means that the Department of Homeland Security (DHS) identified the chemical industry and its employees as an industry sector critical to public health and safety, as well as economic and national security.

Read More

How Refiners Can Capitalise on the Petrochemical Industry

Article | April 6, 2020

Do you fancy a piece of Petrochemical Pie? As the demand for refined products is falling and demand for petrochemical products is increasing, it is vital that refiners consider petrochemical integration, which offers increased flexibility and a competitive edge. Learn more below about the benefits, considerations and recent projects, and, how the double whammy of the oil price crash and the COVID-19 pandemic is affecting the petrochemical market.

Read More

Spotlight

Trevena, Inc.

Trevena, Inc. is a clinical stage biopharmaceutical company that discovers, develops, and intends to commercialize innovative therapies that use a novel approach to target G protein coupled receptors, or GPCRs. We are dedicated to providing value to patients and healthcare providers by improving patient outcomes and reducing healthcare costs. We have identified four biased ligand drug candidates: TRV130, an FDA-designated Breakthrough Therapy, is currently in phase 3 testing for the intravenous treatment of acute moderate to severe pain; TRV027 was evaluated in a Phase 2b study for the treatment.

Events